Ekso Bionics Hires Senior Medical Device Executive for Europe, Middle East, Africa

Ruediger Hausherr Joins Team as President in Europe;
Strategically Builds Team

RICHMOND, Calif., Oct. 1, 2015 (GLOBE NEWSWIRE) — Ekso Bionics
Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton company, today
announced the appointment of industry veteran Ruediger Hausherr to meet
the needs of its expanding European markets.

“I am excited to help Ekso Bionics realize its potential in Europe,
Middle East and Africa,” said Mr. Hausherr. “We are an innovative
company and well-positioned for significant growth in Europe. I believe
we can further strengthen the continued expansion of our healthcare
business and address unmet market needs by offering our innovative
rehabilitation solutions. Our proprietary SmartAssist(TM) software1 for
example, is able to uniquely adapt to the individual and track patient
sessions to optimize progression and support early mobility.”

Mr. Hausherr has over 20 years experience bringing novel new therapies
to market in executive leadership positions in the Orthopedic field;
including having served as CEO / shareholder for ORMED GmbH, which is
now a DJO Global company, a prominent manufacturer of orthotic and
rehabilitation products. He also currently serves as Board member for
several healthcare companies worldwide, contributing to his broad base
of industry know-how and market knowledge.

“We are proud to expand our global business with the addition of
Ruediger Hausherr, who brings extensive knowledge of the rehabilitation
segment as well as of the European healthcare market. We will greatly
benefit from his strategic vision, leadership and proven track record
for developing and delivering value in our target markets,” adds Thomas
Looby, president and chief commercial officer at Ekso Bionics.

To service the increase in clinical demand for its medical exoskeleton
(Ekso GT(TM)), Ekso Bionics has also brought on board Mr. Marco Sauer
as Sales Manager and Mr. Sebastian Stallasch as Clinical Specialist
Therapist. Mr. Sauer will be responsible for driving sales in
German-speaking countries and Mr. Stallasch will be responsible for
therapeutic evaluation of potential patients and training physical
therapists on the Ekso GT as part of the Company’s expansion efforts.

About Ekso Bionics

Since 2005, Ekso Bionics has been pioneering the field of robotic
exoskeletons, or wearable robots, to augment human strength, endurance
and mobility. The company’s first commercially available product called
Ekso has helped thousands of people living with paralysis take millions
of steps not otherwise possible. By designing and creating some of the
most forward-thinking and innovative solutions for people looking to
augment human capabilities, Ekso Bionics is helping people rethink
current physical limitations and achieve the remarkable.

Ekso Bionics is headquartered in Richmond, CA and is listed on the OTC
QB under the symbol EKSO. www.eksobionics.com


CONTACT: Media Contact:
Heidi Darling, Director of Marketing Communications
Phone: 510-984-1761 x317
E-mail: hdarling@eksobionics.com

Investor Contact:
Chad Rubin, Senior Vice President
Phone: 646-378-2947
E-mail: crubin@troutgroup.com